Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol
Key facts
- Who runs it
- University Hospital, Toulouse
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 92 people, planned
- Started
- 1 Feb 2023
- Expected to end
- Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Propranolol Oral Product
- Placebo
- memory reactivation
- Record updated
- 28 August 2023
Who can take part
- Age
- 7 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- Children aged 7-12 years
- CPTS-RI total score ≥40
- Primary diagnosis of PTSD (6 months or more after the traumatic event)
- Heart rate ≥ 55 bpm
- Systolic blood pressure ≥ 95 mm Hg
- Affiliation to a social security scheme
- Written consent signed by the parents/holders of parental authority and the investigator
- Acceptance of the protocol by the child-Child and Parents/Holders of parental authority fluent in French
Who cannot take part
- Concurrent medication with possible interactions with propranolol (cf 8.2)
- Concurrent psychotropic drugs that have been shown to be effective in improving symptoms of PTSD (Antidepressants, atypical antipsychotics, mood stabilizers)
- Concurrent psychotherapy (>1 structured session/month declared by the clinician who follows the child)
- Currently treated with a bradycardic drug
- Concurrent participation to another interventional study
- Contraindication to propranolol (cardiogenic shock, sinus bradycardia, hypotension (< fifth percentile oscillometric or <2SD) (Banker et al., 2016 - see APPENDIX 1), greater than first-degree heart block, heart failure, bronchial asthma and hypersensitivity to propranolol hydrochloride)
- Current active psychosis, anorexia nervosa, bulimia nervosa, binge-eating disorder, attention-deficit hyperactivity disorder, autism spectrum disorder
- Obsessive-compulsive disorders
- Bipolar Disorders
- Renal or Hepatic Impairment
- Age<7 years or ≥13 years
- Children whose parents have been deprived of their authority
- Children with psoriasis
- Children with a predisposition to hypoglycemia
- Mental retardation,
- Traumatic brain injury (loss of consciousness > 10 minutes)
- Pregnancy
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 7 and 12 years old?
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
By age 18, roughly 8% of traumatized youth have met criteria for a diagnosis of PTSD, with numbers rising up to 40% in cases of sexual abuse and assault. To date there is no empirical support for the use of psychopharmacological interventions as treatment of pediatric PTSD. Trauma-focused psychotherapeutic/TFP approaches should be favored in childhood PTSD. However, when compared to active control conditions, TFP produced a mean effect size on child and adolescents population (g=0.83). Moreover, in therapies with a substantial exposure component, the intense and lengthy reexperiencing of the traumatic event results in a substantial proportion of participants dropping out.
Read full original descriptionShow less
The reactivation of a previously consolidated memory can make it labile, subsequently requiring a re-stabilization of it called reconsolidation of the memory.
Acting on these reconsolidation processes makes possible to interfere with the subsequent storage of this memory.
The 2 groups in the trial
- PropranololTreatment being tested
Patient will receive oral propranolol
Treatment: Propranolol Oral Product and memory reactivation
- PlaceboPlacebo, for comparison
Patient will receive oral placebo
Treatment: Placebo and memory reactivation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol: A Randomized Placebo-controlled Trial. PPP
- Criteria questions
- Built from NCT04985344, who can take part
- Record updated
- 28 August 2023